Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

A spokesperson for the Department of Health and Human Services confirmed that Dr. Vinay Prasad, who led the FDA’s Center for ...

Layoffs hit Philly biotech startup after being bought by Big Pharma Tmunity Therapeutics, with ties to Penn Medicine, once raised $231 million from investors. Now workers and its Center City office ...

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...

The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...

Even with the layoffs, the unemployment rate for biotech in April was just 2.8%, according to the Bureau of Labor Statistics.

Since Dr. Vinay Prasad’s appointment as a key political voice within FDA, the tone of U.S. biotech policy has shifted from ...

Headed up by former Merck & Co. executive Roger Perlmutter, M.D., Ph.D., the biotech went on to secure a series of megarounds, with the most ambitious being a $517 million series B in 2022 and the ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they ...

Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, ...

Following an operational review, Waltham, Mass.-based biotech ImmunoGen will lay off 220 employees and suspend some research and development. 3. Walmart cutting some pharmacy jobs ...

Massachusetts’ biotech workforce remained relatively stagnant last year, following several years of slowing growth, according to data released Tuesday by MassBioEd, an industry group focused on ...